CPIX
Price
$3.15
Change
-$0.26 (-7.62%)
Updated
Jul 3 closing price
Capitalization
23.82M
39 days until earnings call
HYPMY
Price
$5.02
Change
+$0.19 (+3.93%)
Updated
Jul 2 closing price
Capitalization
5.79B
Interact to see
Advertisement

CPIX vs HYPMY

Header iconCPIX vs HYPMY Comparison
Open Charts CPIX vs HYPMYBanner chart's image
Cumberland Pharmaceuticals
Price$3.15
Change-$0.26 (-7.62%)
Volume$120.66K
Capitalization23.82M
Hypera SA
Price$5.02
Change+$0.19 (+3.93%)
Volume$944
Capitalization5.79B
CPIX vs HYPMY Comparison Chart in %
Loading...
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPIX vs. HYPMY commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a Hold and HYPMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CPIX: $3.15 vs. HYPMY: $5.03)
Brand notoriety: CPIX and HYPMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CPIX: 180% vs. HYPMY: 3118%
Market capitalization -- CPIX: $23.82M vs. HYPMY: $5.79B
CPIX [@Pharmaceuticals: Other] is valued at $23.82M. HYPMY’s [@Pharmaceuticals: Other] market capitalization is $5.79B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPIX’s FA Score shows that 0 FA rating(s) are green whileHYPMY’s FA Score has 2 green FA rating(s).

  • CPIX’s FA Score: 0 green, 5 red.
  • HYPMY’s FA Score: 2 green, 3 red.
According to our system of comparison, HYPMY is a better buy in the long-term than CPIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPIX’s TA Score shows that 5 TA indicator(s) are bullish while HYPMY’s TA Score has 3 bullish TA indicator(s).

  • CPIX’s TA Score: 5 bullish, 5 bearish.
  • HYPMY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CPIX is a better buy in the short-term than HYPMY.

Price Growth

CPIX (@Pharmaceuticals: Other) experienced а +17.54% price change this week, while HYPMY (@Pharmaceuticals: Other) price change was +9.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

CPIX is expected to report earnings on Aug 12, 2025.

HYPMY is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($5.79B) has a higher market cap than CPIX($23.8M). HYPMY YTD gains are higher at: 71.085 vs. CPIX (32.911). HYPMY has higher annual earnings (EBITDA): 2.86B vs. CPIX (2.49M). HYPMY has higher revenues than CPIX: HYPMY (7.75B) vs CPIX (39.6M).
CPIXHYPMYCPIX / HYPMY
Capitalization23.8M5.79B0%
EBITDA2.49M2.86B0%
Gain YTD32.91171.08546%
P/E RatioN/A15.95-
Revenue39.6M7.75B1%
Total Cash18.3MN/A-
Total Debt18.4MN/A-
FUNDAMENTALS RATINGS
CPIX vs HYPMY: Fundamental Ratings
CPIX
HYPMY
OUTLOOK RATING
1..100
5751
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9379
PRICE GROWTH RATING
1..100
5539
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (15) in the null industry is significantly better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew significantly faster than CPIX’s over the last 12 months.

HYPMY's Profit vs Risk Rating (100) in the null industry is in the same range as CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew similarly to CPIX’s over the last 12 months.

HYPMY's SMR Rating (79) in the null industry is in the same range as CPIX (93) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew similarly to CPIX’s over the last 12 months.

HYPMY's Price Growth Rating (39) in the null industry is in the same range as CPIX (55) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew similarly to CPIX’s over the last 12 months.

HYPMY's P/E Growth Rating (10) in the null industry is significantly better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that HYPMY’s stock grew significantly faster than CPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPIXHYPMY
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE15.760.26
+1.68%
Spyre Therapeutics
BCO94.461.13
+1.21%
Brink's Company (The)
DC3.780.01
+0.27%
Dakota Gold Corp
PCG13.91-0.08
-0.57%
PG&E Corp
ONMD0.55-0.08
-12.54%
OneMedNet Corp

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and AYRWF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and AYRWF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+0.12%
AYRWF - HYPMY
23%
Poorly correlated
-4.96%
PLNH - HYPMY
21%
Poorly correlated
+6.02%
CPIX - HYPMY
20%
Poorly correlated
-7.62%
GLASF - HYPMY
20%
Poorly correlated
+2.88%
KMDA - HYPMY
20%
Poorly correlated
+1.81%
More